التفاصيل البيبلوغرافية
| العنوان: |
Eradication of a Multidrug-Resistant, Carbapenemase-Producing Klebsiella pneumoniae Isolate Following Oral and Intra-rectal Therapy With a Custom Made, Lytic Bacteriophage Preparation. |
| المؤلفون: |
Corbellino, Mario, Kieffer, Nicolas, Kutateladze, Mzia, Balarjishvili, Nana, Leshkasheli, Lika, Askilashvili, Lia, Tsertsvadze, George, Rimoldi, Sara Giordana, Nizharadze, Deia, Hoyle, Naomi, Nadareishvili, Lia, Antinori, Spinello, Pagani, Cristina, Scorza, Daniele Giuseppe, Romanò, Ai Ling Loredana, Ardizzone, Sandro, Danelli, Piergiorgio, Gismondo, Maria Rita, Galli, Massimo, Nordmann, Patrice |
| المصدر: |
Clinical Infectious Diseases; 5/1/2020, Vol. 70 Issue 9, p1998-2001, 4p |
| مصطلحات موضوعية: |
BACTERIAL proteins, BETA lactamases, BIOTHERAPY, COMMUNICABLE diseases, DRUG resistance in microorganisms, KLEBSIELLA, MULTIDRUG resistance, ORAL drug administration, RECTAL medication, VIRUSES, TREATMENT effectiveness |
| مستخلص: |
In July 2017, a patient presented colonization with a multidrug-resistant, carbapenemase (KPC-3)-producing Klebsiella pneumoniae isolate. A custom-made, lytic bacteriophage preparation was administered to the patient in December 2017, with subsequent eradication of the microorganism and without adverse effects. [ABSTRACT FROM AUTHOR] |
|
Copyright of Clinical Infectious Diseases is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
